Healius Limited (ASX:HLS)
0.4550
+0.0150 (3.41%)
Oct 27, 2026, 4:10 PM AEDT
Healius Revenue
In the fiscal year ending June 30, 2026, Healius had annual revenue of 1.37B AUD with 2.16% growth. That makes Healius the 7,771st largest company in the world by revenue and 129th in Australia.
Revenue
1.37B
Revenue Growth
+4.56%
P/S Ratio
0.24
Revenue / Employee
253.40K
Employees
7,494
Market Cap
330.40M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.37B | 29.00M | 2.16% |
| Jun 30, 2025 | 1.34B | 72.40M | 5.69% |
| Jun 30, 2024 | 1.27B | -435.10M | -25.49% |
| Jun 30, 2023 | 1.71B | -582.00M | -25.43% |
| Jun 30, 2022 | 2.29B | 374.70M | 19.57% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Integral Diagnostics | 788.62M |
| Australian Clinical Labs | 736.15M |
| Monash IVF Group | 269.46M |
| ImExHS | 31.27M |
| Genetic Signatures | 19.33M |
| Cryosite | 16.70M |
| Microba Life Sciences | 14.76M |
| BCAL Diagnostics | 2.35M |
Healius News
- 5 days ago - Healius Transcript: AGM 2026 - Transcripts
- 5 days ago - Healius Slides: FY 2026 - Filings
- 2 months ago - Healius Earnings Call Transcript: H2 2026 - Transcripts
- 2 months ago - Healius Slides: H2 2026 - Filings
- 2 months ago - Healius Annual report: H2 2026 - Filings
- 2 months ago - Healius Earnings release: H2 2026 - Filings
- 2 months ago - Healius Annual report: H2 2026 - Filings
- 5 months ago - Healius Earnings release: Trading update - Filings